- Nachrichtendetail
-
08.05.2024 08:09:06 - dpa-AFX: EQS-News: Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery (english)
Media Release: Sensirion product announcement: miniature liquid flow sensor
platform for subcutaneous drug delivery
Sensirion Holding AG / Key word(s): Miscellaneous
Media Release: Sensirion product announcement: miniature liquid flow sensor
platform for subcutaneous drug delivery
08.05.2024 / 08:08 CET/CEST
---------------------------------------------------------------------------
Media Release
08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz
Sensirion product announcement: miniature liquid flow sensor platform for
subcutaneous drug delivery
In the changing landscape of the healthcare industry, Sensirion's SLD3x
series contributes to the improvement of subcutaneous drug delivery with
miniature, and highly accurate digital liquid flow sensors. Customizable
solutions ensure optimal dosing and enhanced patient safety for various
subcutaneous therapies.
Stäfa, Switzerland - The healthcare industry has undergone a significant
transformation in recent years, with an increasing focus on patient and home
care. This shift has been mirrored in the field of drug administration, with
a decrease in hospital stays for certain treatments. The transition from
intravenous to subcutaneous injections using large volume injectors (LVIs)
has been a key driver of this change.
LVIs are wearable devices that enable continuous subcutaneous drug delivery.
They reduce pressure on clinical staff, save costs, and improve patient
comfort. Some LVIs require precise dosing of the delivered drug, which in
turn requires the pump to be controlled by a flow sensor. Moreover, bubbles,
empty lines, occlusion detection, and drug delivery confirmation are
desirable to improve patient safety and the regulatory compliance of the
device.
To meet these needs, Sensirion is developing the SLD3x platform - a series
of digital liquid flow sensors to combine accurate flow measurement,
miniature size, and compatibility with several therapies. This makes it the
ideal solution for medical devices manufactured in large quantities, where
an accurate, disposable liquid flow sensor is required. While flow
measurement is at the heart of the SLD3x platform, it also provides a stream
of data that can be used to detect occlusions, identify in-line air bubbles,
flag up pump malfunctions and measure liquid temperature.
"The SLD3x series features models with maximum flow rates ranging from 100
µl/min to 5 ml/min to meet the varying dosing requirements of different
drugs and treatment protocols. We are happy to discuss the customization of
sensors to meet the unique needs of specific therapies." says Dr. Konrad
Domanski, Product Director Liquid Flow Sensors at Sensirion.
For more information, please visit our product page or join our live webinar
on May 23rd.
SLD3x series at a glance:
Full scale flow rate (H2O) 5 ml/min
Accuracy (H2O) 5 %
Maximum operating pressure 3 bar
Fluidic connector ports Downmount
Supply voltage 3.2 - 3.8 V
Size (LxWxH) 12 x 12 x 3.2 mm3
About Sensirion - Experts for Environmental and Flow Sensor Solutions
Sensirion is one of the world's leading developers and manufacturers of
sensors and sensor solutions that improve efficiency, health, safety, and
comfort. Founded in 1998, Sensirion now employs around 1'200 people at its
headquarters in Stäfa, Switzerland and in numerous international
subsidiaries. Sensirion sensors can be used to measure a wide range of
environmental parameters and flow rates precisely and reliably. The
company's aim is to make the world smarter with advanced sensor technology.
As a pioneer in innovation, Sensirion develops solutions for the specific
needs of customers and partners from the automotive, industrial, medical
technology and consumer electronics markets, as well as high-quality
products for cost-efficient mass production. More information and current
key figures are available at www.sensirion.com.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=c933bd0c82e97404f2a20a8f023fcb0a
File description: Sensirion SLD3x Platform
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
End of News EQS News Service
---------------------------------------------------------------------------
1898195 08.05.2024 CET/CEST
platform for subcutaneous drug delivery
Sensirion Holding AG / Key word(s): Miscellaneous
Media Release: Sensirion product announcement: miniature liquid flow sensor
platform for subcutaneous drug delivery
08.05.2024 / 08:08 CET/CEST
---------------------------------------------------------------------------
Media Release
08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz
Sensirion product announcement: miniature liquid flow sensor platform for
subcutaneous drug delivery
In the changing landscape of the healthcare industry, Sensirion's SLD3x
series contributes to the improvement of subcutaneous drug delivery with
miniature, and highly accurate digital liquid flow sensors. Customizable
solutions ensure optimal dosing and enhanced patient safety for various
subcutaneous therapies.
Stäfa, Switzerland - The healthcare industry has undergone a significant
transformation in recent years, with an increasing focus on patient and home
care. This shift has been mirrored in the field of drug administration, with
a decrease in hospital stays for certain treatments. The transition from
intravenous to subcutaneous injections using large volume injectors (LVIs)
has been a key driver of this change.
LVIs are wearable devices that enable continuous subcutaneous drug delivery.
They reduce pressure on clinical staff, save costs, and improve patient
comfort. Some LVIs require precise dosing of the delivered drug, which in
turn requires the pump to be controlled by a flow sensor. Moreover, bubbles,
empty lines, occlusion detection, and drug delivery confirmation are
desirable to improve patient safety and the regulatory compliance of the
device.
To meet these needs, Sensirion is developing the SLD3x platform - a series
of digital liquid flow sensors to combine accurate flow measurement,
miniature size, and compatibility with several therapies. This makes it the
ideal solution for medical devices manufactured in large quantities, where
an accurate, disposable liquid flow sensor is required. While flow
measurement is at the heart of the SLD3x platform, it also provides a stream
of data that can be used to detect occlusions, identify in-line air bubbles,
flag up pump malfunctions and measure liquid temperature.
"The SLD3x series features models with maximum flow rates ranging from 100
µl/min to 5 ml/min to meet the varying dosing requirements of different
drugs and treatment protocols. We are happy to discuss the customization of
sensors to meet the unique needs of specific therapies." says Dr. Konrad
Domanski, Product Director Liquid Flow Sensors at Sensirion.
For more information, please visit our product page or join our live webinar
on May 23rd.
SLD3x series at a glance:
Full scale flow rate (H2O) 5 ml/min
Accuracy (H2O) 5 %
Maximum operating pressure 3 bar
Fluidic connector ports Downmount
Supply voltage 3.2 - 3.8 V
Size (LxWxH) 12 x 12 x 3.2 mm3
About Sensirion - Experts for Environmental and Flow Sensor Solutions
Sensirion is one of the world's leading developers and manufacturers of
sensors and sensor solutions that improve efficiency, health, safety, and
comfort. Founded in 1998, Sensirion now employs around 1'200 people at its
headquarters in Stäfa, Switzerland and in numerous international
subsidiaries. Sensirion sensors can be used to measure a wide range of
environmental parameters and flow rates precisely and reliably. The
company's aim is to make the world smarter with advanced sensor technology.
As a pioneer in innovation, Sensirion develops solutions for the specific
needs of customers and partners from the automotive, industrial, medical
technology and consumer electronics markets, as well as high-quality
products for cost-efficient mass production. More information and current
key figures are available at www.sensirion.com.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=c933bd0c82e97404f2a20a8f023fcb0a
File description: Sensirion SLD3x Platform
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
Language: English
Company: Sensirion Holding AG
Laubisrütistrasse 50
8712 Stäfa
Switzerland
Phone: +41 44 306 40 00
Fax: +41 44 306 49 06
Internet: www.sensirion.com
ISIN: CH0406705126
Valor: A2JGBW
Listed: Regulated Unofficial Market in Berlin, Frankfurt,
Munich, Stuttgart; SIX Swiss Exchange
EQS News ID: 1898195
End of News EQS News Service
---------------------------------------------------------------------------
1898195 08.05.2024 CET/CEST
